Bowel Perforation After Radiotherapy in a Patient Receiving Sorafenib
Author:
Affiliation:
1. Department of Experimental Oncology, Academic Medical Center, Amsterdam, the Netherlands
2. Department of Radiation Oncology, Academic Medical Center, Amsterdam, the Netherlands
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.15.8451
Reference14 articles.
1. Outcome After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients With Oligometastases
2. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment
3. Phase II Placebo-Controlled Randomized Discontinuation Trial of Sorafenib in Patients With Metastatic Renal Cell Carcinoma
4. Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
5. Targeted Therapy for Metastatic Renal Cell Carcinoma
Cited by 81 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of Gastrointestinal Toxicities Associated with Concurrent Abdominal Radiation Therapy and the Tyrosine Kinase Inhibitor Sunitinib in a Mouse Model;International Journal of Molecular Sciences;2024-02-02
2. Radiotherapy in the management of lung oligometastases;Cancer/Radiothérapie;2024-02
3. Rectal ulcer associated with lenvatinib 15 years after definitive radiotherapy for prostate cancer: A case report;Oncology Letters;2023-11-08
4. Safety and Tolerability of Metastasis-Directed Radiation Therapy in the Era of Evolving Systemic, Immune, and Targeted Therapies;Advances in Radiation Oncology;2022-11
5. Radiation therapy and antiangiogenic therapy: Opportunities and challenges;Cancer/Radiothérapie;2022-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3